Representative before the EPO

Employment test 51 - 200 employees
Company dna mewburn ellis llp
operating since 1890
Headquarter in London and 4 offices
active in Legal Services

We have observed 76 EP applications Seán Malcolm Walton has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after November 29, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12710732

ANTIBODY FC VARIANTS

IPC classification:
C07K 16/28
Applicant:
Roche Glycart AG
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Alexander Burger, Roche Diagnostics GmbH
Status:
GRANT OF PATENT INTENDED
EP12796089

BISMUTH PARTICLE X-RAY CONTRAST AGENTS

IPC classification:
A61L 31/18, A61K 49/04, C08K 9/10, C07F 9/94, B82Y 30/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12810873

IDENTIFICATION OF A WEST NILE VIRUS CD4 T CELL EPITOPE AND USE THEREOF

IPC classification:
C07K 14/18
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12834632

SYSTEM AND METHOD FOR STABILIZING UNINTENTIONAL MUSCLE MOVEMENTS

IPC classification:
A61F 2/68
Applicant:
Verily Life Sciences LLC
Applicant:
Google LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Rainer Gunzelmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Malin Larsson, AWA
Status:
EXAMINATION IN PROGRESS
EP12735490

IMMUNOCYTOKINE COMBINATION THERAPY

IPC classification:
A61K 47/48, A61K 38/20, C07K 16/18, C07K 14/54, C07K 14/525
Agent:
Multiple attorneys, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12787079

FILL FORMULATIONS AND CAPSULES AND METHOD OF USE TO AVOID MIGRATION OF FILL INTO OR THROUGH THE SHELL

IPC classification:
A61K 49/00, A61K 47/38, A61K 47/10, A61K 47/08, A61K 9/48, A61J 3/07, A61B 5/083, A61B 5/08
Applicant:
Capsugel Belgium NV
Agent:
De Clercq & Partners cvba
Agent:
Andrea Macchetta, Capsugel Belgium NV
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP12841016

DENGUE VIRUS E-GLYCOPROTEIN POLYPEPTIDES CONTAINING MUTATIONS THAT ELIMINATE IMMUNODOMINANT CROSS-REACTIVE EPITOPES

IPC classification:
A61K 39/295, A61K 39/12, C12N 15/40, C07K 14/18
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12846033

PEPTIDES AND METHODS FOR THE DETECTION OF LYME DISEASE ANTIBODIES

IPC classification:
G01N 33/543, G01N 33/53, C07K 14/00
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14150323

Formulations for a tight junction effector

IPC classification:
A61K 38/08, A61K 9/50, A61K 9/16
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP12852350

SIGNAL AMPLIFICATION IN LATERAL FLOW AND RELATED IMMUNOASSAYS

IPC classification:
G01N 33/543, G01N 33/53
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12852785

THERAPEUTIC AGENTS COMPRISING INSULIN AMINO ACID SEQUENCES

IPC classification:
A61K 38/28, A61K 38/00, C07H 21/04
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12852490

SYSTEMS AND METHODS FOR HIGH EFFICIENCY ELECTRONIC SEQUENCING AND DETECTION

IPC classification:
C12Q 1/68
Agent:
TLIP Limited
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP14163319

Transmucosal administration of drug compositions for treating and preventing disorders in animals

IPC classification:
A61K 38/13, A61K 31/7048, A61K 31/704, A61K 31/4178, A61K 9/12, A61K 9/00, A01N 25/00
Applicant:
Abbott Laboratories
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12812999

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C12N 15/74, C12N 9/22, C07K 14/195
Applicant:
Wageningen University and Research Centre (Wageningen Universiteit)
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
James Christopher Legg, Avidity IP Ltd
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13190343

Rapid cooling of body and/or brain by irrigating aerodigestive tract with cooling liquid

IPC classification:
A61M 19/00, A61M 16/04, A61H 35/00, A61F 7/12, A61F 7/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13741129

FUSION PROTEINS COMPRISING IGG2 HINGE DOMAINS

IPC classification:
C07K 19/00
Applicant:
University of Maryland Baltimore
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12792320

ANTIBODIES SPECIFIC FOR TGF-BETA

IPC classification:
A61K 39/00, C07K 16/22
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13764092

TOPICALLY ADMINISTERED STRONTIUM-CONTAINING COMPLEXES FOR TREATING PAIN, PRURITIS AND INFLAMMATION

IPC classification:
A61K 33/24, A61K 31/198, A61K 31/192, A61K 31/05
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP12873622

METHODS OF TREATMENT WITH ARGININE DEIMINASE

IPC classification:
A61K 38/00, C07K 14/00
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13758533

USE OF THYMOSIN ALPHA FOR TREATMENT OF PURULENT RHINOSINUSITIS

IPC classification:
A61K 38/22, A61K 38/17, A61P 11/00
Agent:
Jacqueline Frances Moore, Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189746

Methods and compositions for the diagnosis and treatment of lung cancer using KIT gene as genetic marker

IPC classification:
C12Q 1/68
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13726394

SALMONELLA TYPHI TY21A EXPRESSING YERSINIA PESTIS F1-V FUSION PROTEIN AND USES THEREOF

IPC classification:
A61K 39/02, C12N 15/62
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13804259

COMPOSITIONS AND METHODS FOR ENHANCING THE EFFICACY OF CONTRACEPTIVE MICROBICIDES

IPC classification:
A61K 38/00, A61K 9/14, A61K 9/10, A61P 31/18
Agent:
Hendrik Wichmann, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Agent:
Gemma Campabadal i Monfà, Wilson Sonsini Goodrich & Rosati LLP (WSGR)
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14188334

IMPROVED FORMULATIONS AND METHODS FOR LYOPHILIZATION AND LYOPHILATES PROVIDED THEREBY

IPC classification:
A61K 31/175, A61K 9/20, A61K 9/16
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The patent has been granted
EP13810528

A CHEMICAL INDICATOR DEVICE

IPC classification:
G01N 30/74, G01N 21/25, G01N 21/01
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13837832

SENSING SYSTEM

IPC classification:
A61B 3/113, G02C 7/04
Applicant:
Verily Life Sciences LLC
Applicant:
Google LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Matthias Alexander Frenkel, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP14165074

Predicting response to a HER dimerisation inhbitor based on low HER3 expression

IPC classification:
A61K 39/395, G01N 33/574, C12Q 1/68
Applicant:
Genentech, Inc.
Applicant:
F. Hoffmann-La Roche AG
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP13771738

RECOMBINANT LACTOCOCCUS LACTIS EXPRESSING ESCHERICHIA COLI COLONIZATION FACTOR ANTIGEN I (CFA/I) FIMBRIAE AND THEIR METHODS OF USE

IPC classification:
A61K 39/108, A61K 35/74, A61P 37/06
Applicant:
Montana State University-Bozeman
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP13846229

MICROELECTRODES IN AN OPHTHALMIC ELECTROCHEMICAL SENSOR

IPC classification:
G01N 33/48, G01N 27/26
Applicant:
Verily Life Sciences LLC
Applicant:
Google LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Steffen J. Schmidt, Wuesthoff & Wuesthoff Patentanwälte PartG mbB
Status:
GRANT OF PATENT INTENDED
EP13851503

TEMPERATURE CHANGING INTRACORPOREAL FLUID DELIVERY DEVICES

IPC classification:
A61M 39/08, A61M 5/44, A61M 5/168, A61M 5/14, H05B 1/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15163709

THERAPEUTIC AGENTS COMPRISING ELASTIN-LIKE PEPTIDES

IPC classification:
A61K 38/28, A61K 38/00, C07K 1/00, A61P 3/08, A61P 3/04
Applicant:
Duke University
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP13863494

METHODS FOR TREATING PRURITUS

IPC classification:
A61K 31/485, A01N 43/42, A61P 25/00
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP13862044

TRIHEPTANOIN FOR THE TREATMENT OF GLUCOSE TRANSPORTER 1 DEFICIENCY

IPC classification:
A61K 31/23, A61K 31/225, A61P 25/08, A61P 3/02, A61P 3/00
Agent:
Cooley (UK) LLP
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15165133

METHODS OF ADMINISTERING ANTI-TNFALPHA ANTIBODIES

IPC classification:
A61K 39/395, A61K 31/519, C07K 16/24, A61P 37/06, A61P 19/02
Applicant:
AbbVie Biotechnology Ltd
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Harvey Vaughan John Adams, Mathys & Squire LLP
Status:
PATENT GRANTED
EP14735408

THERAPEUTIC VACCINES FOR TREATING HERPES SIMPLEX VIRUS TYPE 2 INFECTIONS

IPC classification:
A61K 39/245, A61K 9/127
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP14745410

IMMUNOGENIC COMPOSITIONS COMPRISING SILICIFIED VIRUS AND METHODS OF USE

IPC classification:
A61K 39/12
Applicant:
Portland State University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
GRANT OF PATENT INTENDED
EP15174585

INSULIN RECEPTOR BINDING ANTIBODIES

IPC classification:
C07K 16/28, C07K 16/26, A61P 3/10, A61K 39/395
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14769521

COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARBOXYHEMOGLOBINEMIA

IPC classification:
C07K 14/795, A61P 39/02, A61K 38/41
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14769754

IN VITRO PRODUCTION OF MEDIAL GANGLIONIC EMINENCE PRECURSOR CELLS

IPC classification:
C12N 5/02, C12N 5/00, C12N 5/071
Applicant:
University of California
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14774486

HIGH FAT HUMAN MILK PRODUCTS

IPC classification:
A23C 9/152, A23C 9/158
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14771135

COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14773031

ADULTERATION TESTING OF HUMAN MILK

IPC classification:
G01N 31/00, G01N 33/48
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14718255

METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY

IPC classification:
A61P 35/00, A61K 31/712, A61K 31/711, A61K 31/7064, A61K 31/706, A61K 31/704, A61K 31/65, A61K 31/52, A61K 31/505, A61K 31/437, A61K 31/365, A61K 31/137, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14800396

DNA-GUIDED DNA INTERFERENCE BY A PROKARYOTIC ARGONAUTE

IPC classification:
C12Q 1/00
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14783323

METHODS, USES AND COMPOSITIONS OF TIE2 AGONISTS

IPC classification:
A61P 31/16, A61K 47/48, A61K 39/395, A61K 31/7056, A61K 31/351, A61K 31/216, A61K 31/195, A61K 31/13, A61K 38/18
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15150112

Combination therapies for B-cell lyphomas comprising administration of anti-CD20 antibody

IPC classification:
C07K 16/30, C07K 16/28, A61K 51/10, C07K 16/00, A61K 38/00, A61K 39/395
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Biogen Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP15185749

HUMANIZED ANTI-BETA7 ANTAGONISTS AND USES THEREFOR

IPC classification:
C07K 16/18, A61K 39/395, C07K 16/28
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP14791718

SOBETIROME IN THE TREATMENT OF MYELINATION DISEASES

IPC classification:
C07C 59/48, A61P 25/28, A61P 25/00, A61K 38/24
Applicant:
Oregon Health & Science University
Applicant:
The United States of America Represented by the Department of Veterans Affairs
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15180834

AVIRULENT, IMMUNOGENIC FLAVIVIRUS CHIMERAS

IPC classification:
C12N 7/01, C12N 15/40, C07K 14/18, A61K 39/295, A61K 39/12
Applicant:
Mahidol University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15178110

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

IPC classification:
G01N 33/68, G01N 33/53, A61P 27/02, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
APPLICATION WITHDRAWN
EP15189714

ANTI-FACTOR XI MONOCLONAL ANTIBODIES AND METHODS OF USE THEREOF

IPC classification:
A61K 39/00, A61K 45/06, A61K 39/395, C07K 16/36
Applicant:
Vanderbilt University - Center for Technology Transfer and Commercialization (CTTC)
Applicant:
Oregon Health & Science University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION IN PROGRESS
EP14813015

SYMMETRICALLY ARRANGED SENSOR ELECTRODES IN AN OPHTHALMIC ELECTROCHEMICAL SENSOR

IPC classification:
G08C 17/00, A61F 2/14, G02C 7/04, G01N 27/416, G01N 27/26
Applicant:
Verily Life Sciences LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The patent has been granted
EP15185944

RECURRENT GENE FUSIONS IN PROSTATE CANCER

IPC classification:
C12Q 1/68
Applicant:
University of Michigan
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP12704201

METHODS AND MATERIALS FOR ENHANCING FUNCTIONAL PROTEIN EXPRESSION IN BACTERIA

IPC classification:
C12N 15/67, C12N 15/62, C07K 14/245, C12N 9/90
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
PATENT GRANTED
EP16169431

MODIFIED CASCADE RIBONUCLEOPROTEINS AND USES THEREOF

IPC classification:
C07K 14/195, C12N 15/74, C12N 9/22
Agent:
Martin Grund, Grund Intellectual Property Group
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The patent has been granted
EP15740660

DIPEPTIDYL PEPTIDASE-4 (DPP4/CD26) AS A PERIPHERAL BIOMARKER OF IL-13 ACTIVATION IN ASTHMATIC LUNG

IPC classification:
G01N 33/53, G01N 33/573, A61K 39/395
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Agent:
Valérie Marie-Noëlle Meyrial, MedImmune Limited
Status:
EXAMINATION REQUESTED
EP15706093

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

IPC classification:
C07K 16/18, G01N 33/68
Applicant:
MedImmune, LLC
Applicant:
Abbott Laboratories
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP15706091

NOVEL ASSAY TO DETECT HUMAN PERIOSTIN

IPC classification:
G01N 33/68, C07K 16/18
Applicant:
MedImmune, LLC
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
EXAMINATION REQUESTED
EP16199297

SCREENING METHODS

IPC classification:
G01N 33/68, G01N 33/557
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16198600

EXTENDING TIME TO DISEASE PROGRESSION OR SURVIVAL IN CANCER PATIENTS

IPC classification:
A61K 39/00, C07K 16/32, C07K 16/30, A61K 31/7068, A61K 45/06, A61P 35/00, A61K 39/395
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP15788253

METHODS TO ELIMINATE CANCER STEM CELLS BY TARGETING CD47

IPC classification:
A61K 39/00, C07K 16/30, C07K 16/28
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP17157837

HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF

IPC classification:
A61P 27/02, C07K 16/18
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP15876253

METHODS OF PREVENTING AND TREATING BRONCHOPULMONARY DYSPLASIA USING HIGH FAT HUMAN MILK PRODUCTS

IPC classification:
A23C 13/14
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP17166798

HUMAN MILK COMPOSITIONS

IPC classification:
A23L 33/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Examination is in progress
EP16711070

TREATMENT OF POST-PRANDIAL HYPERINSULINEMIA AND HYPOGLYCEMIA AFTER BARIATRIC SURGERY

IPC classification:
C07K 16/28
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP17156555

STRONTIUM BASED COMPOSITIONS AND FORMULATIONS FOR PAIN, PRURITUS, AND INFLAMMATION

IPC classification:
A61P 17/04, A61K 31/198, A61K 31/192, A61K 31/05
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16780903

HUMAN MILK COMPOSITIONS AND METHODS OF MAKING AND USING SAME

IPC classification:
A61K 35/20, A61K 31/702, A23C 21/00, A23C 9/14
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16789865

ISOLATED COMPLEX ENDOPHYTE COMPOSITIONS AND METHODS FOR IMPROVED PLANT TRAITS

IPC classification:
A01N 63/04, A01N 63/02, A01H 17/00, A01G 7/06, A01C 1/06
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16789866

DESIGNED COMPLEX ENDOPHYTE COMPOSITIONS AND METHODS FOR IMPROVED PLANT TRAITS

IPC classification:
A01N 63/04, A01N 63/02, A01H 17/00, A01G 7/06, A01C 1/06
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16784014

SMAD7 GENE DELIVERY AS A THERAPEUTIC

IPC classification:
C12N 15/00, A01N 63/00, A61K 48/00
Applicant:
Washington State University
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP16808215

STREPTOMYCES

IPC classification:
A01C 1/06, A01C 1/00, A01N 63/00, A01N 63/02
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP17186130

RAPID ESTABLISHMENT AND/OR TERMINATION OF SUBSTANTIAL STEADY-STATE DRUG DELIVERY

IPC classification:
A61K 38/00, A61K 38/26
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The application has been published
EP17192860

METHODS FOR DETERMINING DIFFERENCES IN ALPHA-4 INTEGRIN ACTIVITY BY CORRELATING DIFFERENCES IN SVCAM AND/OR SMADCAM LEVELS

IPC classification:
G01N 33/68, G01N 33/566, C07K 16/28, A61K 39/395, A61K 39/00
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The application has been published
EP17208162

AMP FOR USE IN TREATING MICROBIAL DISORDERS

IPC classification:
A61P 31/00, A61K 38/16, A61K 38/17, A61K 38/20
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The application has been published
EP16882669

HUMAN MILK PRODUCTS USEFUL IN PRE- AND POST-OPERATIVE CARE

IPC classification:
A23C 9/152, A23C 9/00, A23C 9/20
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
Request for examination was made
EP18157419

COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF

IPC classification:
A61P 35/00, A61K 39/395, C07K 1/18, C07K 16/06, C07K 16/32
Applicant:
Genentech, Inc.
Agent:
Seán Malcolm Walton, Mewburn Ellis LLP
Status:
The application has been published

Please Sign in to use this feature